Format

Send to

Choose Destination
Ann Pharmacother. 1995 Feb;29(2):187-8.

Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity.

Author information

1
Department of Pharmacy Practice and Administration, College of Pharmacy, Rutgers, State University of New Jersey, Piscataway 08855, USA.

Abstract

Because of both an absence of sufficient data and the concern for increased toxicity in certain patient populations, the use of CCBs to reduce radiocontrast-associated nephrotoxicity is not recommended. Additional prospective, randomized trials are needed.

PMID:
7756720
DOI:
10.1177/106002809502900216
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center